Survival Analysis of Liver Transplant Patients in Canada 1997-2002

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 2951-2956

  Hong, Z ^a   Wu, J ^a   Smart, G ^b   Kaita, K ^c   Wen, S W ^d   Paton, S ^a   Dawood, M ^b,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CADHAM PROVINCIAL LABORATORY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d OMNI Research Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ABORIGINE; ADULT; ARTICLE; BLOOD GROUP TYPING; CADAVER; CANADA; CAUCASIAN; ETHNOLOGY; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HUMAN; INTENSIVE CARE UNIT; INTUBATION; KAPLAN MEIER METHOD; LIVER FAILURE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PACIFIC ISLANDER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER;

CANADA; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT;

EID: 33751097745     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.180     Document Type: Article

References (36)

1. Grant D., Stiller C., Duff J., et al. Experience of a Canadian multi-organ transplant service. CMAJ 1353 (1986) 197
2. Gill J: Preliminary statistics on organ donation, transplantation and waiting list: 2005 CORR preliminary report. Canadian Society of Transplantation Annual Meeting, Banff March 18, 2005. Available at http://secure.cihi.ca. Accessed July 16, 2006
3. Ramji A., Yoshida E.M., Bain V.G., et al. Late acute rejection after liver transplantation: the Western Canada Experience. Liver Transpl 810 (2002) 945
4. Anselmo D.M., Ghobrial R.M., Jung L.C., et al. New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg 2355 (2002) 611
5. Liu H., and Liu Y.F. Liver transplantation for patients with viral hepatitis. Hepatobiliary Pancreat Dis Int 21 (2003) 28
6. Fan S.T., Cheung S.T., and Lo C.M. Indicators for liver transplantation in patients with chronic Hepatitis B and C virus infection and hepatocellular carcinoma. J Gastroenterol Hepatol 15 suppl (2000) E191
7. Sherman M., Bain V., Villeneuve J.P., et al. The management of chronic viral hepatitis: a Canadian consensus conference 2004. Can J Infect Dis Med Microbiol 156 (2004) 313
8. Hong Z., Smart G., Zaniewski G., et al. Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003. Eur J Clin Microbiol Infect Dis 24 (2005) 464
9. CORR. One-year survival, Canada, UK and US. Available at http://secure.cihi.ca. Accessed Oct 4, 2005
10. Habib S., Berk B., Chang C.C., et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 123 (2006) 440
11. Malago M, Sotiropoulos GC, Nadalin S, et al: Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl DOI:10.1002/lt.20677, 2006 March 9
12. Rustgi V.K., Marino G., Halpern M.T., et al. Role of gender and ethnicity mismatch and graft failure in patients undergoing liver transplantation. Liver Transpl 86 (2002) 514
13. Smith C.M., Davies D.B., and McBride M.A. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry. In: Cecka, and Terasaki (Eds). Clinical Transplant (1999), UCLA Immunogenetics Centre, Los Angeles, California 23-34
14. Jain A., Reyes J., Kashyap R., et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2324 (2000) 490
15. Belle S.H., Beringer K.C., and Detre K.M. An update on liver transplantation in the United States: recipient characteristics and outcome. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical Transplant (1995), UCLA Immunogenetics Centre, Los Angeles, Calif 19
16. Tonelli M., Hemmelgarn B., Manns B., et al. Death and renal transplantation among Aboriginal people undergoing dialysis. Can Med Assoc J 1716 (2006) 577
17. Matinlauri I.H., Nurminen M.M., Höcherstedt K.A., et al. Risk factors predicting survival of liver transplantation. Transplant Proc 37 (2005) 1155
18. Roque-Afonso A.M., Feray C., Samuel D., et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 501 (2002) 95
19. Sakamoto Y., Takayama T., Nakatsuka T., et al. Advantage in using living donors with aberrant hepatic artery for partial liver graft arterializations. Transplantation 744 (2002) 518
20. Renz J.F., and Roberts J.P. Long-term complications of living donor liver transplantation. Liver Transpl 6 suppl 2 (2000) S73
21. Delmonico F.L., Sheehy E., Marks W.H., et al. Organ donation and utilization in the United States, 2004. Am J Transplant 542 (2005) 862
22. Habib S., Berk B., Chang C.C., et al. MELD and prédiction of post-liver transplantation survival. Liver Transpl 123 (2006) 440
23. Shah B.R., Gunraj N., and Hux J.E. Markers of access to and quality primary care for aboriginal people in Ontario, Canada. Am J Public Health 935 (2003) 798
24. Wardman D., Clement K., and Quantz D. Access and utilization of health service by British Columbia's rural Aboriginal population. Int J Health Care Qual Assur Inc Leadersh Health Serv 182-3 (2005) xxvi
25. Newbold K.B. Problems in search of solutions: health and Canada aboriginals. J Community Health 231 (1998) 59
26. Kim W.R., Poterucha J.J., Kremers W.K., et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 108 (2004) 968
27. Sherman M., Bain V., Villeneuve J.P., et al. The management of chronic viral hepatitis: a Canadian consensus conference 2004. Can J Infect Dis Med Microbiol 156 (2004) 313
28. Wu L.M., Xu X., and Zheng S.S. Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective. Hepatobiliary Pancreat Dis Int 44 (2005) 502
29. Varotti G., Grazi G.L., Vetronea G., et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 194 (2005) 492
30. Schlenker C., and Trotter J. Recurrent hepatitis C following liver transplantation: a review of factors associated with graft injury. Minerva Gastroenterol Dietol 522 (2006) 175
31. Pompili M., Mirante V.G., Rapaccini G.L., et al. Liver transplantation. Ann Ital Med Int 191 (2004) 20
32. Vivarelli M., Cucchetti A., Piscaglia F., et al. Analysis of risk factors for tumor recurence after liver, transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 115 (2005) 497
33. Gunsar F., Rolando N., Pastacaldi S., et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 96 (2003) 605
34. Roche B., and Samuel D. Aspects of hepatitis C virus infection relating to liver transplantation. Eur J Gastroenterol Hepatol 184 (2006) 313
35. Neff G.W., O'Brien C.B., Nery J., et al. Outcomes in liver transplant recipients with hepatitis B virus: resistence and recurrence patterns from a large transplant centre over the last decade. Liver Transpl 10 (2004) 1372
36. Samuel D. Management of hepatitis B in liver transplantation patients. Semin Liver Dis 24 suppl 1 (2004) 55